Skip to main navigation Skip to search Skip to main content

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

  • COVID Surg Collaborative

Research output: Contribution to journalLetterpeer-review

156 Downloads (Pure)

Abstract

There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

Original languageEnglish
Article numberzrab131
Number of pages15
JournalBJS Open
Volume5
Issue number6
DOIs
Publication statusPublished - 8 Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • BCG Vaccine
  • COVID-19
  • Humans
  • SARS-CoV-2
  • Vaccination

Fingerprint

Dive into the research topics of 'Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection'. Together they form a unique fingerprint.

Cite this